Medtronic Gets $250 Million for Three Patent Infringements
May 28, 2008 - A federal jury found that Boston Scientific Corp. has infringed three patents owned by Medtronic, and awarded Medtronic $250 million in damages.
Medtronic sued Boston Scientific in 2006 asserting that Boston's Taxus Express2, Express2, Liberte, Maverick, Maverick2 and Quantum Maverick products infringed the Fitzmaurice and Anderson catheter patents owned by Medtronic. The trial began on Friday, May 16, 2008.
The Fitzmaurice patents cover angioplasty catheters with narrowed distal ends, which improve the deliverability of angioplasty catheters. The Anderson patent covers semicompliant angioplasty balloons. The Anderson balloons provide sufficient strength to withstand repeated inflations allowing custom vessel sizing.
For more information: www.medtronic.com
More like this
- Boston Scientific's Express SD Renal Stent System Receives FDA Clearance
- Cordis, Boston Scientific 14 Stent, Balloon Patent Lawsuits
- Boston Scientific to Fight Patent Decision
- WEB EXCLUSIVE - Making Sense of the Volumes of Stent Presentations Made at TCT 2008
- Court Rejects Two Medtronic Patents, Reduces Boston Scientific Obligations